Package 69367-416-01

Brand: butalbital, aspirin, and caffeine

Generic: butalbital, aspirin, and caffeine
NDC Package

Package Facts

Identity

Package NDC 69367-416-01
Digits Only 6936741601
Product NDC 69367-416
Description

100 CAPSULE in 1 BOTTLE (69367-416-01)

Marketing

Marketing Status
Marketed Since 2025-10-24
Brand butalbital, aspirin, and caffeine
Generic butalbital, aspirin, and caffeine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ac7dfe8b-b751-4ee0-8f41-5e3f4b934c6f", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0369367416016"], "unii": ["R16CO5Y76E", "KHS0AZ4JVK", "3G6A5W338E"], "rxcui": ["238134"], "spl_set_id": ["ac6ceec2-72d8-4901-9d30-278965a79049"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69367-416-01)", "package_ndc": "69367-416-01", "marketing_start_date": "20251024"}], "brand_name": "BUTALBITAL, ASPIRIN, AND CAFFEINE", "product_id": "69367-416_ac7dfe8b-b751-4ee0-8f41-5e3f4b934c6f", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "69367-416", "dea_schedule": "CIII", "generic_name": "BUTALBITAL, ASPIRIN, AND CAFFEINE", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUTALBITAL, ASPIRIN, AND CAFFEINE", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}], "application_number": "ANDA078149", "marketing_category": "ANDA", "marketing_start_date": "20251024", "listing_expiration_date": "20261231"}